Have your own idea? Try our Stock Screener
Vietnamese (HOSE) Healthcare Sector Analysis
UpdatedMar 30, 2026
DataAggregated Company Financials
Companies23
- 7D0.2%
- 3M1.9%
- 1Y2.9%
- YTD1.0%
Over the last 7 days, the Healthcare industry has remained flat, although notably Vidipha Central Pharmaceutical gained 16%. In line with that, the industry has also been flat over the past 12 months. Earnings are forecast to grow by 17% annually.
Sector Valuation and Performance
Has the Vietnamese Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 31 Mar 2026 | ₫51.0t | ₫25.7t | ₫2.3t | 16x | 22.4x | 2x |
| Thu, 26 Feb 2026 | ₫52.4t | ₫25.4t | ₫2.4t | 15.3x | 22.2x | 2.1x |
| Sat, 24 Jan 2026 | ₫51.8t | ₫23.9t | ₫2.3t | 14.4x | 22.2x | 2.2x |
| Mon, 22 Dec 2025 | ₫49.8t | ₫22.3t | ₫2.4t | 15.6x | 21x | 2.2x |
| Wed, 19 Nov 2025 | ₫50.0t | ₫22.3t | ₫2.4t | 15.6x | 21.1x | 2.2x |
| Fri, 17 Oct 2025 | ₫49.8t | ₫21.7t | ₫2.3t | 17.4x | 21.6x | 2.3x |
| Sun, 14 Sep 2025 | ₫50.0t | ₫21.7t | ₫2.3t | 15.8x | 21.7x | 2.3x |
| Tue, 12 Aug 2025 | ₫49.8t | ₫21.7t | ₫2.3t | 16x | 21.6x | 2.3x |
| Thu, 10 Jul 2025 | ₫49.1t | ₫21.3t | ₫2.3t | 18x | 21.8x | 2.3x |
| Sat, 07 Jun 2025 | ₫49.4t | ₫21.6t | ₫2.3t | 17.7x | 21.8x | 2.3x |
| Mon, 05 May 2025 | ₫47.4t | ₫21.6t | ₫2.3t | 17.3x | 20.8x | 2.2x |
| Wed, 02 Apr 2025 | ₫49.4t | ₫21.0t | ₫2.3t | 16.6x | 21.8x | 2.4x |
| Fri, 28 Feb 2025 | ₫50.7t | ₫21.3t | ₫2.2t | 17.3x | 22.8x | 2.4x |
| Sun, 26 Jan 2025 | ₫50.8t | ₫19.5t | ₫2.1t | 17.5x | 24.2x | 2.6x |
| Tue, 24 Dec 2024 | ₫52.5t | ₫19.5t | ₫2.0t | 17.8x | 26.3x | 2.7x |
| Thu, 21 Nov 2024 | ₫47.3t | ₫19.5t | ₫2.0t | 16.8x | 23.7x | 2.4x |
| Sat, 19 Oct 2024 | ₫48.4t | ₫19.6t | ₫2.0t | 15.7x | 24.2x | 2.5x |
| Mon, 16 Sep 2024 | ₫48.2t | ₫19.6t | ₫2.0t | 15.8x | 24x | 2.5x |
| Wed, 14 Aug 2024 | ₫47.1t | ₫19.6t | ₫2.0t | 15.8x | 23.4x | 2.4x |
| Fri, 12 Jul 2024 | ₫47.6t | ₫19.4t | ₫2.2t | 15.8x | 21.5x | 2.5x |
| Sun, 09 Jun 2024 | ₫46.3t | ₫19.4t | ₫2.2t | 16x | 20.9x | 2.4x |
| Tue, 07 May 2024 | ₫42.4t | ₫19.3t | ₫2.2t | 16.1x | 19.1x | 2.2x |
| Thu, 04 Apr 2024 | ₫43.6t | ₫19.2t | ₫2.4t | 14.8x | 18.1x | 2.3x |
| Sat, 02 Mar 2024 | ₫42.4t | ₫19.2t | ₫2.4t | 14.1x | 17.4x | 2.2x |
| Mon, 29 Jan 2024 | ₫40.9t | ₫19.4t | ₫2.4t | 14.1x | 17.2x | 2.1x |
| Wed, 27 Dec 2023 | ₫39.2t | ₫18.9t | ₫2.4t | 14.3x | 16.7x | 2.1x |
| Fri, 24 Nov 2023 | ₫39.5t | ₫18.9t | ₫2.4t | 14x | 16.8x | 2.1x |
| Sun, 22 Oct 2023 | ₫42.1t | ₫17.4t | ₫2.4t | 13.9x | 17.5x | 2.4x |
| Tue, 19 Sep 2023 | ₫43.6t | ₫17.4t | ₫2.4t | 14.2x | 18.4x | 2.5x |
| Thu, 17 Aug 2023 | ₫43.3t | ₫17.4t | ₫2.4t | 14.1x | 18.2x | 2.5x |
| Sat, 15 Jul 2023 | ₫45.1t | ₫17.2t | ₫2.3t | 14x | 19.5x | 2.6x |
| Mon, 12 Jun 2023 | ₫42.1t | ₫17.2t | ₫2.3t | 14.9x | 18.2x | 2.4x |
| Wed, 10 May 2023 | ₫38.7t | ₫17.2t | ₫2.3t | 13.7x | 16.7x | 2.3x |
| Fri, 07 Apr 2023 | ₫34.7t | ₫18.8t | ₫2.4t | 11.6x | 14.5x | 1.8x |
Price to Earnings Ratio
14.5x
Current Industry PE
- Investors are relatively neutral on the Vietnamese Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 20.6x.
- The 3-year average PS ratio of 2.3x is higher than the industry's current PS ratio of 2.0x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 11% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Vietnamese Healthcare sector?
| VN Market | 1.60% | |
| Healthcare | 0.16% | |
| Healthcare Services | 0.35% | |
| Pharma | 0.15% | |
| Medical Equipment | 0% | 0 |
Industry PE
- Investors are most optimistic about the Pharma industry, which is trading close to its 3-year average PE ratio of 19.0x.
- Analysts are expecting annual earnings growth of 17.4%, which is higher than its past year's earnings growth of 4.7% per year.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 17% over the next 5 years.
- This is better than its past earnings growth rate of 4.7% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 17% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| VDP Vidipha Central Pharmaceutical | ₫60.40k | 16.2% +₫185.5b | 74.6% | PE20.9x | |
| DBD Binh Dinh Pharmaceutical and Medical Equipment | ₫51.80k | 3.9% +₫184.3b | -4.1% | PE16.8x | |
| DHG DHG Pharmaceutical | ₫101.00k | 1.2% +₫156.9b | 1.0% | PE16x | |
| IMP Imexpharm | ₫55.00k | 1.1% +₫92.4b | 23.5% | PE27.8x | |
| DHT Ha Tay Pharmaceutical JSC | ₫69.00k | 1.5% +₫90.6b | -12.4% | PE116.5x |